| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $318.8M | -7.1% | +42.2% |
| Cost of Revenue | $213.0M | -4.4% | +21.5% |
| Gross Profit | $105.7M | -12.1% | +116.4% |
| R&D Expense | $10.7M | -19.1% | +18.7% |
| SG&A Expense | $32.0M | +14.6% | +63.4% |
| Operating Income | -$6.3M | -178.0% | -113.0% |
| Pre-tax Income | -$24.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $130.8M | -12.5% | +129.1% |
| Short-term Investments | $7.5M | -55.1% | -89.8% |
| Accounts Receivable | $312.3M | -7.5% | +98.2% |
| Current Assets | $493.7M | -10.4% | +51.4% |
| Total Assets | $1.71B | -3.5% | +223.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $344K | — | — |
| Capital Expenditures | $4.9M | — | — |
| Investing Cash Flow | -$545.4M | — | — |
| Financing Cash Flow | $585.4M | — | — |
| Free Cash Flow | -$4.5M | — | — |
| -21.4% |
| -407.4% |
| Income Tax | -$4.7M | +18.8% | -479.8% |
| Net Income | -$19.7M | -37.6% | -394.1% |
| EPS (Basic) | -$0.21 | -40.0% | -250.0% |
| EPS (Diluted) | -$0.21 | -40.0% | -2200.0% |
| $455.5M |
| -9.4% |
| +67.0% |
| Long-term Debt | $604.0M | +0.2% | — |
| Total Liabilities | $1.19B | -4.0% | +293.7% |
| Stockholders' Equity | $519.3M | -2.4% | +128.6% |